Sign in
4

Changes in Ownership

CYTOKINETICS INC Filed Acc 0001127602-23-014289

EVP Research & Development sold 7,000 shares at $40.00 ($280,000)

  • EVP Research & Development acquired 7,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Malik Fady Ibraham · EVP Research & Development

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-05-03 Exercise or conversion : show line 1 in the form 10b5-1 +7,000 $7.96 $55,720 174,183 D
2023-05-03 Sale : show line 2 in the form 10b5-1 −7,000 $40.00 $280,000 167,183 D
Open-market sales · 7,000 sh · avg $40.00 · $280,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-05-03 Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (Right to Buy) −7,000 74,322 D
Loading xslF345X04/form4.xml…